BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10519413)

  • 1. Identification and characterization of genes associated with human hepatocellular carcinogenesis.
    Kondoh N; Wakatsuki T; Ryo A; Hada A; Aihara T; Horiuchi S; Goseki N; Matsubara O; Takenaka K; Shichita M; Tanaka K; Shuda M; Yamamoto M
    Cancer Res; 1999 Oct; 59(19):4990-6. PubMed ID: 10519413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas.
    Tanaka K; Kondoh N; Shuda M; Matsubara O; Imazeki N; Ryo A; Wakatsuki T; Hada A; Goseki N; Igari T; Hatsuse K; Aihara T; Horiuchi S; Yamamoto N; Yamamoto M
    Biochim Biophys Acta; 2001 Apr; 1536(1):1-12. PubMed ID: 11335099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and significance of tumor-related genes in HCC.
    Lü ZL; Luo DZ; Wen JM
    World J Gastroenterol; 2005 Jul; 11(25):3850-4. PubMed ID: 15991281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
    Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
    Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma.
    Kondoh N; Shuda M; Tanaka K; Wakatsuki T; Hada A; Yamamoto M
    Anticancer Res; 2001; 21(4A):2429-33. PubMed ID: 11724303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients.
    Flannery PC; Abbott KL; Pondugula SR
    Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):297-304. PubMed ID: 31792727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.
    Li X; Zhang W; Zhou L; Yue D; Su X
    Int J Clin Exp Pathol; 2015; 8(10):12455-63. PubMed ID: 26722432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
    Qiu W; David D; Zhou B; Chu PG; Zhang B; Wu M; Xiao J; Han T; Zhu Z; Wang T; Liu X; Lopez R; Frankel P; Jong A; Yen Y
    Am J Pathol; 2003 Jun; 162(6):1961-74. PubMed ID: 12759252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells.
    Maruyama M; Matsunaga T; Harada E; Ohmori S
    Biol Pharm Bull; 2007 Nov; 30(11):2091-7. PubMed ID: 17978482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
    Hsu HC; Cheng W; Lai PL
    Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
    Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma.
    Gong Y; Cui L; Minuk GY
    Mol Cell Biochem; 2000 Apr; 207(1-2):101-4. PubMed ID: 10888233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes.
    Schuetz EG; Schuetz JD; Strom SC; Thompson MT; Fisher RA; Molowa DT; Li D; Guzelian PS
    Hepatology; 1993 Nov; 18(5):1254-62. PubMed ID: 8225233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
    Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
    Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma.
    Hsu DK; Dowling CA; Jeng KC; Chen JT; Yang RY; Liu FT
    Int J Cancer; 1999 May; 81(4):519-26. PubMed ID: 10225438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma.
    Masaki T; Tokuda M; Ohnishi M; Watanabe S; Fujimura T; Miyamoto K; Itano T; Matsui H; Arima K; Shirai M; Maeba T; Sogawa K; Konishi R; Taniguchi K; Hatanaka Y; Hatase O; Nishioka M
    Hepatology; 1996 Jul; 24(1):72-81. PubMed ID: 8707286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HOX gene network in hepatocellular carcinoma.
    Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
    Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans.
    Lamba JK; Chen X; Lan LB; Kim JW; Wei Wang X; Relling MV; Kazuto Y; Watkins PB; Strom S; Sun D; Schuetz JD; Schuetz EG
    Pharmacogenet Genomics; 2006 Jun; 16(6):415-27. PubMed ID: 16708050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.